TIVC Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Benzinga - Mentions: ZYXI ITRM ARVN OLMA ...

12 Health Care Stocks Moving In Tuesday's Intraday Session

5 days ago - By: ACCESS Newswire

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

8 days ago - By: ACCESS Newswire

Tivic Reports Third Quarter 2025 Financial Results

9 days ago - By: Benzinga - Mentions: NXXT DEFT INKT CMDB ...

Earnings Scheduled For November 14, 2025

10 days ago - By: ACCESS Newswire

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

13 days ago - By: Tivic Health Systems, Inc.

Tivic Expands Intellectual Property Portfolio

17 days ago - By: Tivic Health Systems, Inc.

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

a month ago - By: Tivic Health Systems, Inc.

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

2 months ago - By: Tivic Health Systems, Inc.

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference

2 months ago - By: Tivic Health® Systems, Inc.

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

3 months ago - By: Tivic Health Systems, Inc.

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

3 months ago - By: Tivic Health Systems, Inc.

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

3 months ago - By: The Motley Fool

Tivic Health (TIVC) Q2 2025 Earnings Transcript

3 months ago - By: The Motley Fool

Tivic Health Sales Drop 39 Percent

3 months ago - By: Tivic Health Systems, Inc.

Tivic Reports Second Quarter 2025 Financial Results

4 months ago - By: Tivic Health® Systems, Inc.

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

5 months ago - By: Tivic Health Systems, Inc.

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

5 months ago - By: Tivic Health Systems, Inc.

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

5 months ago - By: Tivic Health Systems, Inc.

Tivic Health Announces 2025 Annual Meeting of Stockholders

5 months ago - By: Virtual Investor Conferences - Mentions: NIKA ADIA STSS SBC ...

Life Sciences Investor Forum: Now Available for Online Viewing

6 months ago - By: Virtual Investor Conferences - Mentions: NIKA ADIA STSS SBC ...

Life Sciences Investor Forum Agenda Announced for June 11th-12th

6 months ago - By: ACCESS Newswire - Mentions: ULY HTCR DGXX LWLG ...

Sidoti Events, LLC's Virtual May Micro-Cap Conference

6 months ago - By: Tivic Health Systems, Inc.

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

6 months ago - By: Tivic Health Systems, Inc. - Mentions: OTC SCPX

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

6 months ago - By: Tivic Health Systems, Inc.

Tivic Expands VNS Intellectual Property Portfolio

7 months ago - By: Tivic Health Systems, Inc.

TIVIC HEALTH SYSTEMS INC (TIVC) Stock News

TIVC Latest News, Press Relases and Analysis

12 Health Care Stocks Moving In Tuesday's Intraday Session

Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome

Tivic Reports Third Quarter 2025 Financial Results

Earnings Scheduled For November 14, 2025

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

Tivic Expands Intellectual Property Portfolio

Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference

Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Tivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Health (TIVC) Q2 2025 Earnings Transcript

Tivic Health Sales Drop 39 Percent

Tivic Reports Second Quarter 2025 Financial Results

Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

Tivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device

Tivic Health Announces 2025 Annual Meeting of Stockholders

Life Sciences Investor Forum: Now Available for Online Viewing

Life Sciences Investor Forum Agenda Announced for June 11th-12th

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation

Tivic Health Enters GMP Manufacturing Validation Agreement with Scorpius BioManufacturing in Preparation for FDA Submission

Tivic Expands VNS Intellectual Property Portfolio

Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast